Fludarabine, Cyclophosphamide, and Rituximab or Alemtuzumab in Treating CLL2007 CLL 2007 FMP

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00564512
Recruitment Status : Completed
First Posted : November 28, 2007
Last Update Posted : July 25, 2013
Information provided by (Responsible Party):
French Innovative Leukemia Organisation